Heptral - instructions for use, analogs, reviews and release forms (400 mg tablets, injections in ampoules for intravenous and intramuscular injections) of a drug for the treatment of liver diseases in adults, children and in pregnancy
In this article, you can read the instructions for using the drug Heptral. Presented are reviews of visitors to the site - consumers of this medication, as well as opinions of physicians specialists on the use of Geptral in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Heptral in the presence of existing structural analogues. Use for the treatment of liver diseases in adults, children, as well as during pregnancy and lactation.
Heptral - hepatoprotector, has antidepressant activity. Has choleretic and cholekinetic effect. It has detoxification, regenerating, antioxidant, antifibrozing and neuroprotective properties.
Replenishes the deficit of ademetionine (the active substance of the drug Geptral) and stimulates its production in the body, primarily in the liver and brain. Participates in biological reactions of transmethylation (methyl group donor) - the S-adenosyl-L-methionine molecule (ademethionine) donates the methyl group in the reactions of methylation of phospholipids of cell membranes, proteins, hormones, neurotransmitters; transsulfation - the precursor of cysteine, taurine, glutathione (provides redox mechanism of cellular detoxification), coenzyme acetylation. Increases the glutamine content in the liver, cysteine and Taurine in plasma; reduces the content of methionine in the serum, normalizing metabolic reactions in the liver. After decarboxylation it participates in aminopropylation processes as a precursor of polyamines-putrescine (stimulator of cell regeneration and proliferation of hepatocytes), spermidine and spermine, which are part of the ribosome structure.
Has a choleretic effect due to increased mobility and polarization of hepatocyte membranes, due to stimulation of the synthesis of phosphatidylcholine in them. This improves the function of hepatocyte-associated transport systems of bile acids and promotes the passage of bile acids into the biliary system. Effective with intraloble variant of cholestasis (a violation of synthesis and current of bile). It contributes to the detoxification of bile acids, increases the content of conjugated and sulfated bile acids in hepatocytes. Conjugation with taurine increases the solubility of bile acids and their removal from the hepatocyte. The process of sulphation of bile acids contributes to the possibility of their elimination by the kidneys, facilitates the passage through the membrane of the hepatocyte and excretion with bile. In addition, sulfated bile acids protect the liver cells from the toxic effect of non-sulphated bile acids (in high concentrations present in hepatocytes with intrahepatic cholestasis). In patients with diffuse liver disease (cirrhosis, hepatitis) with intrahepatic cholestasis syndrome reduces the severity of skin itching and changes in biochemical parameters, incl.level of direct bilirubin, activity of alkaline phosphatase, aminotransferases.
Choleretic and hepatoprotective effects persist up to 3 months after discontinuation of treatment.
Efficacy is shown for hepatopathies due to hepatotoxic drugs.
The administration of the drug to patients with opioid addiction, accompanied by liver damage, leads to regression of clinical manifestations of abstinence, improvement of the functional state of the liver and the processes of microsomal oxidation.
Antidepressant activity manifests itself gradually, beginning with the end of the first week of treatment, and stabilized within 2 weeks of treatment. The drug is effective in recurrent endogenous and neurotic depressions resistant to amitriptyline. Has the ability to interrupt recurrence of depression.
The purpose of the drug in osteoarthritis reduces the severity of the pain syndrome, increases the synthesis of proteoglycans and leads to partial regeneration of the cartilaginous tissue.
Pharmacokinetics
The tablets are covered with a special shell that dissolves only in the intestines, due to this ademetionin is released in the duodenum.Binding to serum proteins is negligible. Penetrates through the blood-brain barrier. Regardless of the route of administration, a significant increase in the concentration of ademetionine in the cerebrospinal fluid is noted. Biotransformatsya in the liver. It is excreted by the kidneys.
Indications
- chronic acalculous cholecystitis;
- cholangitis;
- intrahepatic cholestasis;
- toxic liver damage of various etiologies (including alcohol, viral, drug / antibiotics, antitumor agents, antituberculosis and antiviral drugs, tricyclic antidepressants, oral contraceptives);
- fatty degeneration of the liver;
- chronic hepatitis;
- cirrhosis of the liver;
- encephalopathy, incl. associated with hepatic insufficiency (including alcoholic);
- depression (including secondary);
- abstinence syndrome (including alcohol).
Forms of release
The tablets covered with a cover, soluble in an intestine of 400 mg.
Lyophilizate for the preparation of solution for intravenous and intramuscular injection (injections in ampoules for injections).
Instructions for use and dosage
Pills
The drug is prescribed by mouth in a daily dose of 800-1600 mg. The duration of maintenance therapy can be on average 2-4 weeks.
Tablets should be swallowed whole, not liquid, preferably taken in the morning, between meals.
Ampoules
Apply intravenously or intramuscularly.
The lyophilizate must be dissolved in a specially applied solvent immediately before administration. The rest of the drug must be disposed of.
The drug should not be mixed with alkaline solutions and solutions containing calcium ions.
In case the lyophilizate has a color different from almost white to white with a yellowish tinge (due to a crack in the vial or heat exposure), the Heptral drug should not be used.
The drug Heptral with intravenous administration is administered very slowly.
Initial therapy
The recommended dose is 5-12 mg / kg per day in / in or / m.
Intrahepatic cholestasis
The drug is administered at a dose of 400 mg per day to 800 mg per day (1-2 vials a day) for 2 weeks.
Depression
The drug is administered at a dose of 400 mg per day to 800 mg per day (1-2 vials a day) for 15-20 days.
If necessary, maintenance therapy is recommended to continue taking Heptral in the form of tablets at a dose of 800-1600 mg per day for 2-4 weeks.
Side effect
- gastralgia;
- dyspepsia;
- heartburn;
- allergic reactions.
Contraindications
- 1 and 2 trimester of pregnancy;
- lactation period (breastfeeding);
- age to 18 years;
- hypersensitivity to the components of the drug.
Application in pregnancy and lactation
It is not recommended to appoint Heptral in the first and second trimesters of pregnancy and lactation (breastfeeding).
Use in children
Contraindicated in children and adolescents under the age of 18 years.
special instructions
Given the tonic effect of Heptral, it is not recommended to apply before bedtime.
With the appointment of Heptral, patients with cirrhosis of the liver against a background of hyperaemia require a systematic control of the level of Nitrogen in the blood. During prolonged therapy, it is necessary to determine the content of urea and creatinine in the blood serum.
The solution is prepared immediately before use; if the color of the lyophilized powder differs from that of the white powder, it is necessary to refrain from using it.
Drug Interactions
There was no known drug interaction between Heptral and other drugs.
Analogues of the medicinal product Heptral
Structural analogs for the active substance:
- S-adenosyl-L-methionine disulfate p-toluenesulfonate;
- S-Adenosylmethionine;
- Ademethionine 1,4-butanedisulfonate;
- Heptor;
- Heptor N.
Similar medicines:
Other medicines:
- Eufillin - instructions for use, reviews, analogs and forms of release (tablets of 150 mg, injections in ampoules for injections in solution intravenously and intramuscularly) drugs for the treatment of bronchial obstruction in adults, children and in pregnancy
- Aksamon - instructions for use, analogues,reviews and release forms (20 mg tablets) of a medicament for the treatment of Alzheimer's disease, paresis and paralysis in adults, children and in pregnancy
- Diprospan - instructions for use, analogs, reviews and release forms (suspension or solution in injection injections in ampoules (including for intra-articular administration)) of the drug for the treatment of inflammation in adults, children and in pregnancy